Dorzy Drop

Dorzy Drop contains dorzolamide hydrochloride , an inhibitor of human carbonic anhydrase. Following topical administration, DORZY reduces elevated intraocular pressure. Elevated intraocular a major risk factor in the pathogenesis of optic nerve damage and glaucomatous visual loss.

Key Ingredients:

• Dorzolamide Hydrochloride

• Equivalent to Dorzolamide

• Benzalkonium Cholride Solution

• Sterile Aqueous Vehicle

Key Benefits:

• It contains dorzolamide hydrochloride , an inhibitor of human carbonic anhydrase.

• It reduces elevated intraocular pressure.

• Helpful in pathogenesis of optic nerve damage and glaucomatous visual loss.

Directions for use:

• One drop of DORZY is to be instilled in affected eye three times daily

• It may be used concomitantly with other topical ophthalmic solution drug products to lower intraocular pressure

• If more than one ophthalmic drug is being used, the drugs should be administered at least ten minutes apart

Safety Information:

• Read the label carefully before use

• Store in a cool and dry place, away from sunlight

• Keep out of the reach of children